HIN SANG GROUP (INTERNATIONAL) HOLDING CO. LTD.

Hin Sang Group (International) Holding Co. Ltd.

6893

KYG4590V1023

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:28 2024-05-24 EDT			5-day change	1st Jan Change
0.27 ^HKD	-6.90%		-6.90%	-19.40%

05-17	Hin Sang Group (International) Holding Co. Ltd. Announces Executive Changes	CI
02-19	Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary, Effective 19 February 2024	CI

Hin Sang Group (International) Holding Co. Ltd. Announces Resignation of Mok Tsan San as Executive Director, Effective September 30, 2015

September 30, 2015 at 05:19 am

The board of directors of Hin Sang Group (International) Holding Co. Ltd. announced that Mr. Mok Tsan San resigned as an executive director of the company with effect from 30 September 2015 due to other new commitments.

Latest news about Hin Sang Group (International) Holding Co. Ltd.

Hin Sang Group (International) Holding Co. Ltd. Announces Executive Changes	05-17	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary, Effective 19 February 2024	02-19	CI
Hin Sang Group Narrows Fiscal H1 Loss	11-30	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2023	11-29	CI
Hin Sang's Loss to Narrow in Fiscal H1	11-20	MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Six Months Ended 30 September 2023	11-17	CI
Hin Sang Group's Fiscal Year 2023 Loss Widens Four Times	23-06-29	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-29	CI
Hin Sang Excepts Loss to Widen for Fiscal Year 2023	23-06-26	MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Financial Year Ended 31 March 2023	23-06-23	CI
Hin Sang Group’s April-Sept Loss Widens as Revenue Falls 4%	22-11-29	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-29	CI
Hin Sang Group (International) Holding Co. Ltd. Auditor Raises 'Going Concern' Doubt	22-07-27	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Management Changes, Effective 1 July 2022	22-06-30	CI
Hin Sang Group Logs $1.7 Million Net Loss in FY22	22-06-29	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-28	CI
Hin Sang Expects Decrease in FY22 Net Loss; Shares Climb 3%	22-06-24	MT
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Year Ended 31 March 2022	22-06-23	CI
Hin Sang Group Unit Ties Up with Hongli Homologous Biotechnology to Open Chain Stores in China	21-12-30	MT
Hin Sang Group (International) Holding Co. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-22	CI
Hin Sang Group (International) Holding Co. Ltd. Appoint Tian Shanshan as A Non-Executive Director with Effect from 1 December 2021	21-11-22	CI
Hin Sang Group (International) Holding Co. Ltd. Provides Earnings Guidance for the Six Months Ended September 30, 2021	21-11-12	CI
Hin Sang Group (International) Holding Co. Ltd. Announces the Retirement of Yuen Chi Ping as Non-Executive Director	21-09-29	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Change of Company Secretary	21-08-02	CI
Hin Sang Group (International) Holding Co. Ltd. Announces Unaudited Consolidated Earnings Results for the Year Ended 31 March 2021	21-07-29	CI

Chart Hin Sang Group (International) Holding Co. Ltd.

Duration

Period

Chart Hin Sang Group (International) Holding Co. Ltd.

More charts

Company Profile

Hin Sang Group (International) Holding Co. Ltd. is an investment holding company principally engaged in development, marketing and sales of care products, healthcare products and household products under various brands. The Company operates its business through three segments. The Product Development segment is engaged in the sales of products developed by the Company under own brands. The Brand Development and Management segment is engaged in the sales and distribution of products with exclusive distribution rights. The Trading of Goods segment is engaged in the sales and distribution of products purchased from authorized dealers, independent traders, manufacturers and parallel importers.

Sector

Pharmaceuticals

Calendar

2024-06-24 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HIN SANG GROUP (INTERNATIONAL) HOLDING CO. LTD.	-19.40%	40.55M
ELI LILLY AND COMPANY	+38.51%	728B
NOVO NORDISK A/S	+33.05%	603B
JOHNSON & JOHNSON	-6.23%	360B
MERCK & CO., INC.	+18.78%	332B
ABBVIE INC.	+1.35%	279B
ASTRAZENECA PLC	+16.00%	244B
NOVARTIS AG	+8.09%	207B
ROCHE HOLDING AG	-5.77%	205B
AMGEN INC.	+6.19%	164B